Investigating how IgE antibodies contribute to allergic diseases
Understanding IgE Biology
This study is looking into how your immune system makes IgE antibodies that can cause allergies, with the goal of finding ways to prevent or treat allergic reactions, including severe ones like anaphylaxis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11030260 on NIH RePORTER |
What this research studies
This research focuses on understanding the biology of IgE antibodies, which are crucial in the development of allergic diseases. It examines how B cells produce IgE in response to allergens and the subsequent activation of immune cells that can lead to allergic reactions, including severe anaphylaxis. The study aims to uncover the mechanisms that control IgE production and its distribution in the body, which could provide insights into preventing or treating allergic conditions. By analyzing gene expression and the role of cytokines, the research seeks to identify potential targets for therapeutic intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from allergic diseases, such as asthma, hay fever, or food allergies.
Not a fit: Patients with non-allergic conditions or those who do not produce IgE antibodies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating allergic diseases, improving the quality of life for affected patients.
How similar studies have performed: Previous research has shown promising results in understanding IgE biology and its role in allergic diseases, indicating that this approach has potential for significant advancements.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Wesemann, Duane R. — Brigham and Women's Hospital
- Study coordinator: Wesemann, Duane R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.